Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOMATROGON-GHLA for Hypopituitarism: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 38 adverse event reports in the FDA FAERS database where SOMATROGON-GHLA was used for Hypopituitarism.

Most Reported Side Effects for SOMATROGON-GHLA

Side Effect Reports % Deaths Hosp.
Injection site pain 738 69.8% 0 2
Wrong technique in device usage process 43 4.1% 0 0
Injection site erythema 42 4.0% 0 0
Incorrect dose administered by device 41 3.9% 0 0
Injection site swelling 38 3.6% 0 0
Off label use 29 2.7% 0 3
Patient-device incompatibility 29 2.7% 0 0
Headache 27 2.6% 0 3
Needle issue 27 2.6% 0 0
Device mechanical issue 24 2.3% 0 0
Device delivery system issue 23 2.2% 0 0
Incorrect dose administered 22 2.1% 0 0
Drug dose omission by device 21 2.0% 0 0
Injection site mass 21 2.0% 0 0
Device leakage 19 1.8% 0 0

Other Indications for SOMATROGON-GHLA

Growth hormone deficiency (373) Dwarfism (110) Short stature (31) Blood growth hormone (5) Blood growth hormone decreased (5)

Other Drugs Used for Hypopituitarism

SOMATROPIN (5,842) LONAPEGSOMATROPIN-TCGD (225) HYDROCORTISONE (208) LEVOTHYROXINE (84) TESTOSTERONE (67) DESMOPRESSIN (53) DUPILUMAB (29) SOMATREM (22) NUTROPIN AQ (20) CORTISONE (14)

Related Pages

SOMATROGON-GHLA Full Profile All Hypopituitarism Drugs SOMATROGON-GHLA Demographics SOMATROGON-GHLA Timeline